Recent breakthroughs in the field of obesity treatment have generated a new therapy known as ALLUVI Retatrutide. This substance is a {highlypotent GLP-1 receptor agonist, designed to mimic the effects of natural glucagon-like peptide-1. Retatrutide has shown impressive outcomes in clinical trials, demonstrating significant losses in body weight and